Home - Products - Others - Other Targets - 24-Diamino-6-hydroxypyrimidine

24-Diamino-6-hydroxypyrimidine

CAS No. 56-06-4

24-Diamino-6-hydroxypyrimidine( DAHP )

Catalog No. M20881 CAS No. 56-06-4

24-Diamino-6-hydroxypyrimidine (DAHP) is a selective specific inhibitor of GTP cyclohydrolase I the rate limiting step for de novo pterin synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    24-Diamino-6-hydroxypyrimidine
  • Note
    Research use only, not for human use.
  • Brief Description
    24-Diamino-6-hydroxypyrimidine (DAHP) is a selective specific inhibitor of GTP cyclohydrolase I the rate limiting step for de novo pterin synthesis.
  • Description
    24-Diamino-6-hydroxypyrimidine (DAHP) is a selective specific inhibitor of GTP cyclohydrolase I the rate limiting step for de novo pterin synthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DAHP
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GTP cyclohydrolase I
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56-06-4
  • Formula Weight
    126.12
  • Molecular Formula
    C4H6N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:25 mg/mL (198.22 mM)
  • SMILES
    Nc1cc(=O)[nH]c(N)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sung Y J Hotchkiss J H Dieteri R R . 24-diamino-6-hydroxypyrimidine an inhibitor of GTP cyclohydrolase I suppresses nitric oxide production by chicken macrophages[J]. International Journal of Immunopharmacology 1994 16(2):101-108.
molnova catalog
related products
  • Ginsenoside Rg5

    Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease.

  • 2-(Acetyloxy)-3-Meth...

    qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 with activity value of 19.95 μM.

  • Lapisteride

    Lapisteride (CS-891) a steroidal 5α-reductase inhibitor is used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia and may be effective in preventing or treating AGA .